Loading…

Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma

Despite combined treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating that a more efficient and local therapy is needed. In this way, vascular-targeted photodynamic therapy (VTP) could help tumor eradication by destroying its neovessels. In this study, we designe...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Nanomedicine 2017, Vol.12, p.7075
Main Authors: Thomas, Eloise, Colombeau, Ludovic, Gries, Mickael, Peterlini, Thibaut, Mathieu, Clelia, Thomas, Noemie, Boura, Cedric, Frochot, Celine, Vanderesse, Regis, Lux, Frangois, Barberi-Heyob, Muriel, Tillement, Olivier
Format: Report
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page 7075
container_title International Journal of Nanomedicine
container_volume 12
creator Thomas, Eloise
Colombeau, Ludovic
Gries, Mickael
Peterlini, Thibaut
Mathieu, Clelia
Thomas, Noemie
Boura, Cedric
Frochot, Celine
Vanderesse, Regis
Lux, Frangois
Barberi-Heyob, Muriel
Tillement, Olivier
description Despite combined treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating that a more efficient and local therapy is needed. In this way, vascular-targeted photodynamic therapy (VTP) could help tumor eradication by destroying its neovessels. In this study, we designed a polysiloxane-based nanoparticle (NP) combining a magnetic resonance imaging (MRI) contrast agent, a photosensitizer (PS) and a new ligand peptide motif (KDKPPR) targeting neuropilin-1 (NRP-1), a receptor overexpressed by angiogenic endothelial cells of the tumor vasculature. This structure achieves the detection of the tumor tissue and its proliferating part by MRI analysis, followed by its treatment by VTP. The photophysical properties of the PS and the peptide affinity for NRP-1 recombinant protein were preserved after the functionalization of NPs. Cellular uptake of NPs by human umbilical vein endothelial cells (HUVEC) was increased twice compared to NPs without the KDKPPR peptide moiety or conjugated with a scramble peptide. NPs induced no cytotoxicity without light exposure but conferred a photocytotoxic effect to cells after photodynamic therapy (PDT). The in vivo selectivity, evaluated using a skinfold chamber model in mice, confirms that the functionalized NPs with KDKPPR peptide moiety were localized in the tumor vessel wall.
doi_str_mv 10.2147/IJN.S141559
format report
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A532303282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A532303282</galeid><sourcerecordid>A532303282</sourcerecordid><originalsourceid>FETCH-gale_infotracmisc_A5323032823</originalsourceid><addsrcrecordid>eNqNjrtOw0AQRbcAifCo-IGRqB32EWOnjBCPUNAAEl00OGtn0XjX2pkg5e9ZIT4g1T3FuVdXqWuj59Ysmtv1y-v8zSxMXS9P1MyYpq2sNu5MnTN_a1037d1ypvIHSUYekQhWT_v1J8jOZ4yJJXQQC0yYC5Jn6FOGH-RuT5grwTx48VsIUXwutgQkmHZJ0vYQcSztv6XpAKmHgUL6ImRJI16q0x6J_dV_Xqibx4f3--dqQPKbEPtUHnVj4G6zqp112tnWuuOsX_RAUIc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma</title><source>Taylor &amp; Francis_OA刊</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Thomas, Eloise ; Colombeau, Ludovic ; Gries, Mickael ; Peterlini, Thibaut ; Mathieu, Clelia ; Thomas, Noemie ; Boura, Cedric ; Frochot, Celine ; Vanderesse, Regis ; Lux, Frangois ; Barberi-Heyob, Muriel ; Tillement, Olivier</creator><creatorcontrib>Thomas, Eloise ; Colombeau, Ludovic ; Gries, Mickael ; Peterlini, Thibaut ; Mathieu, Clelia ; Thomas, Noemie ; Boura, Cedric ; Frochot, Celine ; Vanderesse, Regis ; Lux, Frangois ; Barberi-Heyob, Muriel ; Tillement, Olivier</creatorcontrib><description>Despite combined treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating that a more efficient and local therapy is needed. In this way, vascular-targeted photodynamic therapy (VTP) could help tumor eradication by destroying its neovessels. In this study, we designed a polysiloxane-based nanoparticle (NP) combining a magnetic resonance imaging (MRI) contrast agent, a photosensitizer (PS) and a new ligand peptide motif (KDKPPR) targeting neuropilin-1 (NRP-1), a receptor overexpressed by angiogenic endothelial cells of the tumor vasculature. This structure achieves the detection of the tumor tissue and its proliferating part by MRI analysis, followed by its treatment by VTP. The photophysical properties of the PS and the peptide affinity for NRP-1 recombinant protein were preserved after the functionalization of NPs. Cellular uptake of NPs by human umbilical vein endothelial cells (HUVEC) was increased twice compared to NPs without the KDKPPR peptide moiety or conjugated with a scramble peptide. NPs induced no cytotoxicity without light exposure but conferred a photocytotoxic effect to cells after photodynamic therapy (PDT). The in vivo selectivity, evaluated using a skinfold chamber model in mice, confirms that the functionalized NPs with KDKPPR peptide moiety were localized in the tumor vessel wall.</description><identifier>ISSN: 1178-2013</identifier><identifier>DOI: 10.2147/IJN.S141559</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>Brain tumors ; Care and treatment ; Glioblastomas ; Magnetic resonance imaging ; Photochemotherapy</subject><ispartof>International Journal of Nanomedicine, 2017, Vol.12, p.7075</ispartof><rights>COPYRIGHT 2017 Dove Medical Press Limited</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4476,27901</link.rule.ids></links><search><creatorcontrib>Thomas, Eloise</creatorcontrib><creatorcontrib>Colombeau, Ludovic</creatorcontrib><creatorcontrib>Gries, Mickael</creatorcontrib><creatorcontrib>Peterlini, Thibaut</creatorcontrib><creatorcontrib>Mathieu, Clelia</creatorcontrib><creatorcontrib>Thomas, Noemie</creatorcontrib><creatorcontrib>Boura, Cedric</creatorcontrib><creatorcontrib>Frochot, Celine</creatorcontrib><creatorcontrib>Vanderesse, Regis</creatorcontrib><creatorcontrib>Lux, Frangois</creatorcontrib><creatorcontrib>Barberi-Heyob, Muriel</creatorcontrib><creatorcontrib>Tillement, Olivier</creatorcontrib><title>Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma</title><title>International Journal of Nanomedicine</title><description>Despite combined treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating that a more efficient and local therapy is needed. In this way, vascular-targeted photodynamic therapy (VTP) could help tumor eradication by destroying its neovessels. In this study, we designed a polysiloxane-based nanoparticle (NP) combining a magnetic resonance imaging (MRI) contrast agent, a photosensitizer (PS) and a new ligand peptide motif (KDKPPR) targeting neuropilin-1 (NRP-1), a receptor overexpressed by angiogenic endothelial cells of the tumor vasculature. This structure achieves the detection of the tumor tissue and its proliferating part by MRI analysis, followed by its treatment by VTP. The photophysical properties of the PS and the peptide affinity for NRP-1 recombinant protein were preserved after the functionalization of NPs. Cellular uptake of NPs by human umbilical vein endothelial cells (HUVEC) was increased twice compared to NPs without the KDKPPR peptide moiety or conjugated with a scramble peptide. NPs induced no cytotoxicity without light exposure but conferred a photocytotoxic effect to cells after photodynamic therapy (PDT). The in vivo selectivity, evaluated using a skinfold chamber model in mice, confirms that the functionalized NPs with KDKPPR peptide moiety were localized in the tumor vessel wall.</description><subject>Brain tumors</subject><subject>Care and treatment</subject><subject>Glioblastomas</subject><subject>Magnetic resonance imaging</subject><subject>Photochemotherapy</subject><issn>1178-2013</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2017</creationdate><recordtype>report</recordtype><sourceid/><recordid>eNqNjrtOw0AQRbcAifCo-IGRqB32EWOnjBCPUNAAEl00OGtn0XjX2pkg5e9ZIT4g1T3FuVdXqWuj59Ysmtv1y-v8zSxMXS9P1MyYpq2sNu5MnTN_a1037d1ypvIHSUYekQhWT_v1J8jOZ4yJJXQQC0yYC5Jn6FOGH-RuT5grwTx48VsIUXwutgQkmHZJ0vYQcSztv6XpAKmHgUL6ImRJI16q0x6J_dV_Xqibx4f3--dqQPKbEPtUHnVj4G6zqp112tnWuuOsX_RAUIc</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Thomas, Eloise</creator><creator>Colombeau, Ludovic</creator><creator>Gries, Mickael</creator><creator>Peterlini, Thibaut</creator><creator>Mathieu, Clelia</creator><creator>Thomas, Noemie</creator><creator>Boura, Cedric</creator><creator>Frochot, Celine</creator><creator>Vanderesse, Regis</creator><creator>Lux, Frangois</creator><creator>Barberi-Heyob, Muriel</creator><creator>Tillement, Olivier</creator><general>Dove Medical Press Limited</general><scope/></search><sort><creationdate>20170101</creationdate><title>Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma</title><author>Thomas, Eloise ; Colombeau, Ludovic ; Gries, Mickael ; Peterlini, Thibaut ; Mathieu, Clelia ; Thomas, Noemie ; Boura, Cedric ; Frochot, Celine ; Vanderesse, Regis ; Lux, Frangois ; Barberi-Heyob, Muriel ; Tillement, Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracmisc_A5323032823</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Brain tumors</topic><topic>Care and treatment</topic><topic>Glioblastomas</topic><topic>Magnetic resonance imaging</topic><topic>Photochemotherapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Thomas, Eloise</creatorcontrib><creatorcontrib>Colombeau, Ludovic</creatorcontrib><creatorcontrib>Gries, Mickael</creatorcontrib><creatorcontrib>Peterlini, Thibaut</creatorcontrib><creatorcontrib>Mathieu, Clelia</creatorcontrib><creatorcontrib>Thomas, Noemie</creatorcontrib><creatorcontrib>Boura, Cedric</creatorcontrib><creatorcontrib>Frochot, Celine</creatorcontrib><creatorcontrib>Vanderesse, Regis</creatorcontrib><creatorcontrib>Lux, Frangois</creatorcontrib><creatorcontrib>Barberi-Heyob, Muriel</creatorcontrib><creatorcontrib>Tillement, Olivier</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomas, Eloise</au><au>Colombeau, Ludovic</au><au>Gries, Mickael</au><au>Peterlini, Thibaut</au><au>Mathieu, Clelia</au><au>Thomas, Noemie</au><au>Boura, Cedric</au><au>Frochot, Celine</au><au>Vanderesse, Regis</au><au>Lux, Frangois</au><au>Barberi-Heyob, Muriel</au><au>Tillement, Olivier</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma</atitle><jtitle>International Journal of Nanomedicine</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>12</volume><spage>7075</spage><pages>7075-</pages><issn>1178-2013</issn><abstract>Despite combined treatments, glioblastoma outcome remains poor with frequent local recurrences, indicating that a more efficient and local therapy is needed. In this way, vascular-targeted photodynamic therapy (VTP) could help tumor eradication by destroying its neovessels. In this study, we designed a polysiloxane-based nanoparticle (NP) combining a magnetic resonance imaging (MRI) contrast agent, a photosensitizer (PS) and a new ligand peptide motif (KDKPPR) targeting neuropilin-1 (NRP-1), a receptor overexpressed by angiogenic endothelial cells of the tumor vasculature. This structure achieves the detection of the tumor tissue and its proliferating part by MRI analysis, followed by its treatment by VTP. The photophysical properties of the PS and the peptide affinity for NRP-1 recombinant protein were preserved after the functionalization of NPs. Cellular uptake of NPs by human umbilical vein endothelial cells (HUVEC) was increased twice compared to NPs without the KDKPPR peptide moiety or conjugated with a scramble peptide. NPs induced no cytotoxicity without light exposure but conferred a photocytotoxic effect to cells after photodynamic therapy (PDT). The in vivo selectivity, evaluated using a skinfold chamber model in mice, confirms that the functionalized NPs with KDKPPR peptide moiety were localized in the tumor vessel wall.</abstract><pub>Dove Medical Press Limited</pub><doi>10.2147/IJN.S141559</doi></addata></record>
fulltext fulltext
identifier ISSN: 1178-2013
ispartof International Journal of Nanomedicine, 2017, Vol.12, p.7075
issn 1178-2013
language eng
recordid cdi_gale_infotracmisc_A532303282
source Taylor & Francis_OA刊; Publicly Available Content Database; PubMed Central
subjects Brain tumors
Care and treatment
Glioblastomas
Magnetic resonance imaging
Photochemotherapy
title Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T14%3A14%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Ultrasmall%20AGuIX%20theranostic%20nanoparticles%20for%20vascular-targeted%20interstitial%20photodynamic%20therapy%20of%20glioblastoma&rft.jtitle=International%20Journal%20of%20Nanomedicine&rft.au=Thomas,%20Eloise&rft.date=2017-01-01&rft.volume=12&rft.spage=7075&rft.pages=7075-&rft.issn=1178-2013&rft_id=info:doi/10.2147/IJN.S141559&rft_dat=%3Cgale%3EA532303282%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-gale_infotracmisc_A5323032823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A532303282&rfr_iscdi=true